Considerations for Child Cancer Survivors and Immunocompromised Children to Prevent Secondary HPV-associated Cancers
PublisherWolters Kluwer Health
MetadataShow full item record
AbstractSurvivors of childhood cancer and other immunocompromised children are at high risk for the development of secondary human papillomavirus (HPV)-associated cancers. In this overview, the authors examine the epidemiology of vaccine efficacy, the natural history of HPV infections, and accelerated HPV-associated cancer development in these populations. The authors highlight the opportunities for preventive care and future research directives.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/15145
- HPV vaccination of immunocompromised hosts.
- Authors: Garland SM, Brotherton JML, Moscicki AB, Kaufmann AM, Stanley M, Bhatla N, Sankaranarayanan R, de Sanjosé S, Palefsky JM, IPVS
- Issue date: 2017 Dec
- Inducing Immunity Where It Matters: Orthotopic HPV Tumor Models and Therapeutic Vaccinations.
- Authors: Zottnick S, Voß AL, Riemer AB
- Issue date: 2020
- Implications for human papillomavirus in penile cancer.
- Authors: Flaherty A, Kim T, Giuliano A, Magliocco A, Hakky TS, Pagliaro LC, Spiess PE
- Issue date: 2014 Jan
- Human papillomavirus vaccines.
- Authors: Satyaprakash A, Creed R, Ravanfar P, Mendoza N
- Issue date: 2009 Mar-Apr
- No Vacillation on HPV Vaccination.
- Authors: Sipp D, Frazer IH, Rasko JEJ
- Issue date: 2018 Mar 8